Last updated: September 22, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mood Disorders
Depression (Major/severe)
Depression
Treatment
Brain stimulation
Clinical Study ID
NCT05239780
STUDY-17-00258
1R01MH124763-01
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The study will follow clinical criteria for epilepsy patient recruitment for invasive monitoring. As a results, individuals of adults of all ages are expected to be included in this study.
Exclusion
Exclusion Criteria:
Adults over 80 years of age will be excluded as per concerns of cognitive decline.
Children under 18 will be excluded from the study since the maturation of frontallobes continues through adolescence and significant differences in frontal lobefunctioning between children younger than 18 and adults are often observed.
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Brain stimulation
Phase:
Study Start date:
October 06, 2021
Estimated Completion Date:
August 31, 2027
Study Description
Connect with a study center
Icahn School of Medicine at Mount Sinai
New York, New York 100119
United StatesSite Not Available
Icahn School of Medicine at Mount Sinai
New York 5128581, New York 5128638 100119
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.